The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111831046 11183104 6 F 2014 20160725 20150611 20160802 EXP CA-ABBVIE-15K-028-1404031-00 ABBVIE 0.00 F Y 127.12000 KG 20160802 MD COUNTRY NOT SPECIFIED CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111831046 11183104 1 PS HUMIRA ADALIMUMAB 1 Subcutaneous Y N 6060574 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN /wk
111831046 11183104 2 SS HUMIRA ADALIMUMAB 1 Subcutaneous Y N 6060574 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN /wk
111831046 11183104 3 SS HUMIRA ADALIMUMAB 1 Subcutaneous Y N 6060574 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN QOW
111831046 11183104 4 SS XARELTO RIVAROXABAN 1 Oral U UNKNOWN 0
111831046 11183104 5 SS PENICILLIN NOS PENICILLIN 1 Oral UNKNOWN 0
111831046 11183104 6 SS SERC BETAHISTINE HYDROCHLORIDE 1 Unknown UNKNOWN 0
111831046 11183104 7 C METHOTREXATE. METHOTREXATE 1 0
111831046 11183104 8 C FOLIC ACID. FOLIC ACID 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111831046 11183104 1 Crohn's disease
111831046 11183104 4 Pulmonary thrombosis
111831046 11183104 5 Pharyngitis
111831046 11183104 6 Vertigo
111831046 11183104 7 Crohn's disease
111831046 11183104 8 Crohn's disease

Outcome of event

Event ID CASEID OUTC COD
111831046 11183104 HO
111831046 11183104 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
111831046 11183104 Allergic oedema
111831046 11183104 Aphthous ulcer
111831046 11183104 Arthralgia
111831046 11183104 Back pain
111831046 11183104 Crohn's disease
111831046 11183104 Cystitis
111831046 11183104 Drug hypersensitivity
111831046 11183104 Drug ineffective
111831046 11183104 Eye infection
111831046 11183104 Fatigue
111831046 11183104 Gastrointestinal stoma complication
111831046 11183104 Intervertebral disc degeneration
111831046 11183104 Intestinal polyp
111831046 11183104 Kidney infection
111831046 11183104 Mobility decreased
111831046 11183104 Pharyngitis
111831046 11183104 Pneumonia
111831046 11183104 Pulmonary embolism
111831046 11183104 Pulmonary thrombosis
111831046 11183104 Rash
111831046 11183104 Somnolence
111831046 11183104 Stoma site haemorrhage
111831046 11183104 Stoma site ulcer
111831046 11183104 Thrombosis
111831046 11183104 Vertigo
111831046 11183104 Vomiting
111831046 11183104 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111831046 11183104 1 20090610 201412 0
111831046 11183104 2 201607 0
111831046 11183104 3 201607 0
111831046 11183104 5 2014 2014 0